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Stem cell decline is an important cellular driver of aging-associated pathophysiology in multiple tissues.
Epigenetic regulation is central to establishing and maintaining stem cell function, and emerging evidence
indicates that epigenetic dysregulation contributes to the altered potential of stem cells during aging. Unlike
terminally differentiated cells, the impact of epigenetic dysregulation in stem cells is propagated beyond self;
alterations can be heritably transmitted to differentiated progeny, in addition to being perpetuated and ampli-
fied within the stem cell pool through self-renewal divisions. This Review focuses on recent studies exam-
ining epigenetic regulation of tissue-specific stem cells in homeostasis, aging, and aging-related disease.Introduction
Tissue-specific stem cells are imbuedwith self-renewal potential
and the capacity for differentiation to generate mature effector
cells, and thus they are responsible for sustained function of tis-
sues throughout life. Aging is associated with the progressive
inability to maintain tissue homeostasis or robustly regenerate
tissue after injury or stress. These processes aremediated by tis-
sue-specific stem cells, suggesting that impaired stem cell func-
tion may underlie central cellular pathophysiologies associated
with aging. Indeed, mounting evidence indicates that degenera-
tive aging-associated changes in adult stem cells are a central
driver of many age-related phenotypes (reviewed in Oh et al.,
2014; Liu and Rando, 2011; Behrens et al., 2014; Rossi et al.,
2008). The mechanistic basis for aging-associated stem cell
decline is not completely understood, but numerous studies
have shown that loss of polarity (Florian et al., 2012), mitochon-
drial dysfunction (Bratic and Larsson, 2013), altered autophagy
(Warr et al., 2013), replicative stress (Flach et al., 2014), and
accrual of DNA damage (Rossi et al., 2007; Ru¨be et al., 2011; Ya-
hata et al., 2011; Wang et al., 2012; Beerman et al., 2014) all
contribute to stem cell aging. In addition, increasing evidence
suggests that epigenetic dysregulation is also an important
mechanistic driver of stem cell aging.
Epigenetic regulation is a term used to classify heritable
changes of gene expression that are not attributed to changes
in DNA sequence (Waddington, 1942; Goldberg et al., 2007;
Bird, 2007). Epigenetic marks, including but not restricted to
DNA methylation and histone modifications, allow all cells within
an organism to possess the same genetic sequence yet carry out
vastly different functions. The particular epigenetic landscape of
each cell both restricts and permits access to genes that collec-
tively coordinate the transcriptional programs unique to each cell
type. In differentiated cells, epigenetic regulation is used not only
to coordinate ongoing cellular activity but also to restrict access
to lineage-inappropriate gene programs (Hodges et al., 2011; Ji
et al., 2010; Bock et al., 2012; Kaaij et al., 2013). Importantly,
stem cells have potential beyond self-renewal and can differen-
tiate into cells with distinct potentials and, in some instances,can generate a large repertoire of effector cells with enormous
functional diversity. The epigenetic landscape of stem cells not
only regulates the transcriptional programs that dictate the func-
tion of the stem cells themselves but must also possess the
potential to coordinate differentiation toward distinct effector
lineages. Stem cells heritably transmit epigenetic marks to their
daughter cells, and thus marks set in the stem cell can prime
lineage-specific loci for activation or repression in downstream
progeny. Epigenetic alterations arising in stem cells can be
perpetuated and amplified within the stem cell pool via self-
renewal divisions (horizontal transmission) where they may
have a direct, autonomous functional consequence in the stem
cell compartment. Altered epigenomic marks propagated in
this fashion can alter the clonal composition of the stem cell
pool, particularly if a selective advantage or disadvantage is
conferred. Clones imbued with a competitive advantage can
in turn serve as the reservoir in which additional genetic or
epigenetic alterations could arise and could eventually lead to
malignancy (Figure 1). In addition, heritable alterations of the
epigenetic landscape arising in stem cells can be transmitted
to differentiated progeny with functional consequences manifest
in downstream lineages (vertical transmission) (Figure 1).
This Review will focus on research that establishes the func-
tional importance of epigenetic regulation in multiple tissue-spe-
cific stem cells and how dysregulation is associated with aging
and disease. These topics will be discussed in the context
of altered DNA methylation, changes in histone modifications,
and synergistic relationships between epigenetic and genomic
integrity.
DNA Methylation and the Regulation of Stem Cell
Function and Aging
In mammalian cells, DNA methylation predominantly occurs at
CpG dinucleotides.Methylated cytosine (mC) is found throughout
the genome at high frequency, predominantly located at pro-
moter regions of housekeeping and developmental regulation
genes, though it is underrepresented at CpG islands (regions
with a high occurrence of CpGs). DNA methylation is catalyzedCell Stem Cell 16, June 4, 2015 ª2015 Elsevier Inc. 613
Figure 1. Stem Cell Aging and Epigenetic Dysregulation
Proper epigenetic regulation of stem cells is critical for the maintenance of
tissue and is of particular importance given stem cells’ capacity to heritably
transmit epigenetic marks to their progeny (Vertical Transmission) and to
perpetuate and amplify alterations through self-renewal divisions (Horizontal
Transmission). Vertical transmission of aging-associated altered epigenetic
marks can drive functional consequences in downstream progenitor or
effector cells (red fill), while stem cell clones that acquire aging-associated
epigenetic alterations providing a selective advantage (blue fill) can lead to an
expanded stem cell pool that can serve as the cellular reservoir in which
addition events—epigenetic (color fill) or genetic (pattern)—can be accrued
that may eventually lead to malignancy.
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(DNMT3A and DNMT3B) and maintenance (DNMT1) of methyl-
atednucleotides, and togetherwith regulatedDNAdemethylation,
they generate tissue- and cell-type-specific marks that regulate
gene expression to coordinate cellular function.
Dynamic Regulation of DNA Methylation and
Demethylation Orchestrates Stem Cell Function
DNMT1 maintains methylation marks by binding hemi-methyl-
ated sites generated after replication and adding a methyl group
to cytosines on the newly synthesized daughter strand. Compel-
ling evidence indicates that DNMT1 coordinates the balance be-
tween self-renewal and differentiation in multiple adult stem cell
compartments. In the skin, knockdown of Dnmt1 leads to dimin-
ished self-renewal and premature differentiation of epidermal
progenitor cells, ultimately leading to tissue loss (Sen et al.,
2010). Similarly, conditional knockout of Dnmt1 leads to
decreased proliferation, abnormal differentiation, and compro-
mised self-renewal of bulge stem cells (Li et al., 2012). In neural
stem cells (NSCs), loss of DNMT1 prematurely drives differenti-
ation toward astroglia (Fan et al., 2001, 2005), while intestinal
stem cells lacking DNMT1 display inhibited differentiation poten-
tial (Sheaffer et al., 2014). In hematopoietic stem cells (HSCs),
loss of DNMT1 leads to defects in both self-renewal and differen-
tiation potential, leading to a skewed lineage output biased to-
ward myelopoiesis (Trowbridge et al., 2009; Bro¨ske et al.,
2009). The altered lineage output of DNMT1-deficient stem
cells also suggests that at least a subset of methylation marks
present in the stem cell compartment establish the lineage po-
tential of stem cells manifest in downstream lineages. Interest-
ingly, many of the phenotypes associated with loss of DNMT1
mirror those associated with aging, including myeloid lineage
skewing of the aged hematopoietic compartment, abnormal
bulge cell differentiation, and age-related increases in astro-
cytes. Together, these data suggest that altered DNA methyl-614 Cell Stem Cell 16, June 4, 2015 ª2015 Elsevier Inc.ation may play a role in underwriting the functional decline asso-
ciated with stem cell aging in these tissues.
In recent years, numerous studies have demonstrated that
unique DNA methylation marks are established as adult stem
cells undergo differentiation (Hodges et al., 2011; Ji et al.,
2010; Bock et al., 2012; Kaaij et al., 2013), suggesting that de
novo methylation is critical for stem cell differentiation. Indeed,
impaired differentiation is seen in postnatal Dnmt3a knockout
mouse NSCs (Wu et al., 2010). Similarly, conditional knockout
of Dnmt3a in HSCs leads to increased self-renewal at the
expense of differentiation (Challen et al., 2012), a phenotype
that is exacerbated upon ablation of both Dnmt3a and Dnmt3b
(Challen et al., 2014). These studies demonstrate that tissue-
specific stem cells require de novo DNA methylation to restrict
self-renewal potential and direct differentiation.
DNA demethylation can occur through various processes,
including active demethylation via progressive oxidation of mC
catalyzed by ten-eleven translocation (Tet) family enzymes (Tahi-
liani et al., 2009; Ito et al., 2010). Demethylation by TET enzymes
can be amulti-step process, in which the initial step is generation
of 5-hydroxymethylcytosine (5-hmC). Interestingly, 5-hmC is
quite prevalent in the brains of mice and humans (Kriaucionis
and Heintz, 2009; Mu¨nzel et al., 2011), prompting analysis of
the role of TETs in neural progenitor cells (NPCs). Loss of
TET1 in NPCs decreases their self-renewal potential without
affecting their differentiation potential. TET1-deficient mice
display impaired learning and poor memory, which correlates
with increased methylation and decreased expression of genes
involved in the proliferation of NPCs (Zhang et al., 2013).
In vitro studies using NPCs derived from Tet3 knockout ESCs
further establish the role for 5mC-oxidases in primitive neural
cells, as loss of TET3 led to dysregulation of the maintenance
of the NPC population associated with increased apoptosis
(Li et al., 2015).
In contrast, loss of TET2 in the HSC compartment leads to a
profound increase in HSC self-renewal (Ko et al., 2011; Moran-
Crusio et al., 2011; Shide et al., 2012). In addition, Tet2 knock-
outs also have abnormally high levels of myeloid lineage output
(Ko et al., 2011; Moran-Crusio et al., 2011; Shide et al., 2012)
and develop a chronic myelomonocytic leukemia (CMML)-like
disease (Moran-Crusio et al., 2011). Interestingly, Tet1 deletion
also leads to enhanced self-renewal of HSCs, but Tet1 null
HSCs also have an increased bias toward B cell production
and develop B cell malignancies (Cimmino et al., 2015). Consis-
tent with demonstrated functional overlap of these TET family
proteins during development (Dawlaty et al., 2011), these studies
suggest a conserved role for Tet proteins in regulating HSC self-
renewal, yet each protein also plays unique roles in regulating the
differentiation of distinct lineages from HSCs.
In addition to TET-mediated DNA demethylation, studies
have reported that growth arrest and DNA-damage-inducible
(GADD45) family members can also mediate the active removal
of 5mC (Barreto et al., 2007; Ma et al., 2009; Schmitz et al.,
2009). GADD45 family members are best known for their role
in DNA damage response. Though they do not have known enzy-
matic demethylase activity, they are proposed to demethylate
DNA through interactions with other proteins involved in base
excision and/or nucleotide excision repair (Sen et al., 2010).
Together with the recruited DNA repair proteins, GADD45
Figure 2. DNA Methylation Patterns in Stem Cells during Aging and
Cancer
A representation of DNA methylation patterns of HSCs during aging (Young
and Aged) and those reported for multiple types of cancers (Cancer). Though
these regions illustrated are not necessarily restricted to a single category (for
example bivalent domains can also be PcG targets), we present a simple
overview of the aging-associated gains of methylation that are predominantly
found at CpG islands near promoter regions, bivalent domains, and on PcG
target regions and the loss of methylation that occurs throughout the genome
and at repeat elements in HSCs.
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genes to promote their transcriptional activation andmediate dif-
ferentiation in several tissue-specific stem cell compartments.
Consistently, combinatory loss of GADD45A/GADD45B in epi-
dermal progenitor cells prevented differentiation, which was
attributed to impaired removal of DNA methylation at loci that
are typically hypo-methylated during differentiation (Sen et al.,
2010). Conversely, overexpression of Gadd45A or Gadd45B
prompted premature differentiation at the expense of epidermal
progenitor cell expansion, supporting a role for these proteins
in regulating differentiation. In mesenchymal stem cells, deme-
thylation of promoter regions in osteogenic lineage genes
correlated with upregulation of Gadd45A, and knockdown of
Gadd45A led to hyper-methylation of these regions, loss of oste-
ogenic gene expression, and inhibition of differentiation (Zhang
et al., 2011). Gadd45B has also been implicated to play a critical
role in adult, activity-driven neurogenesis (Ma et al., 2009).
Together, these studies suggest that GADD45 proteins play a
role in DNA demethylation necessary for tissue-specific stem
cell differentiation, though it is yet unclear what underwrites
target specificity.
Altered DNA Methylation in Aged Stem Cells
As noted above, dysregulation of DNA methylation leads to
aberrant stem cell function with phenotypes frequently mirroring
those observed with aging, supporting the possibility that
alterations of this epigenetic mark may underlie certain aspects
of the aging process. Early studies examining global DNA
methylation patterns in aged somatic tissues largely demon-
strate age-associated hypo-methylation (Wilson and Jones,
1983; Gonzalo, 2010; Heyn et al., 2012), which was also
observed in cultured cells that reached their replicative limit
(Wilson and Jones, 1983). Upon more detailed analysis, several
studies uncovered locus-specific DNA hyper-methylation asso-
ciated with aging tissues (Maegawa et al., 2010; Gro¨nniger et al.,
2010; Rakyan et al., 2010; Zykovich et al., 2014). Regions that
gain methylation with age (regardless of tissue) were commonly
found in CpG islands (Christensen et al., 2009; Yuan et al., 2015;
Heyn et al., 2012) and were over-represented for targets of poly-
comb group (PcG) proteins (discussed below) (Maegawa et al.,
2010). Interestingly, certain aging-associated hyper-methylation
changes universally correlate with age regardless of tissue type(Bocklandt et al., 2011; Koch and Wagner, 2011; Rakyan et al.,
2010; Horvath et al., 2012), suggesting some level of coordinated
control of the DNA methylome during aging. Furthermore,
several studies examining DNA methylation in human peripheral
blood have revealed altered profiles associated with aging (Heyn
et al., 2012; Christensen et al., 2009; Bell et al., 2012). However,
as the frequency distribution of blood cell types dramatically
changes with age, with increased preponderance of myeloid
cells and diminished lymphoid cells, analyses of whole blood
may reflect altered effector cell frequencies rather than aging-
specific DNA methylation differences per se. To address this, al-
gorithms have been developed to account for differences in cell
composition (Koestler et al., 2013; Houseman et al., 2012) or
make reference-free adjustments using a bootstrap method to
estimate error (Houseman et al., 2014). Using such approaches,
recent analysis of human blood samples has indeed established
that the majority of hyper-methylation seen with aging was inde-
pendent of changes in cellular composition and was instead
linked directly to cellular aging (Yuan et al., 2015). Because pe-
ripheral blood is composed of diverse cell types originating
from a pool of stem cells, these data therefore suggest the
observed aging-associated DNA methylation changes origi-
nated in the stem cell compartment with all differentiated prog-
eny inheriting the altered methylation marks.
To more directly address the impact of aging on the DNA
methylome of stem cells, recent studies have examined the
global DNA methylation profiles of purified stem cells isolated
from young and old mice (Figure 2). These studies show that
HSCs display global hyper-methylation during aging (Beerman
et al., 2013, Sun et al., 2014) concomitant with decreased
5-hmC levels (Sun et al., 2014). As has been observed with aging
in other systems (Maegawa et al., 2010), aging-associated gains
of DNA methylation were over-represented at loci associated
with PcG binding in pluripotent stem cells (Beerman et al.,
2013; Sun et al., 2014). Similarly, PcG targets were also hyper-
methylated in mesenchymal stromal cells during aging or after
extended passaging, though a predominance of aging-associ-
ated hypo-methylation was reported (Bork et al., 2010; Ferna´n-
dez et al., 2015).
These studies also assayed the correlation between age-
associated DNA methylation changes and the transcriptional
alterations associated with aging. Consistently, the altered
DNA methylation profiles that were identified did not have a
direct effect on transcription in stem cells—increased DNA
methylation did not correlate with decreased gene expression,
and conversely, decreased DNAmethylation was not associated
with increased expression of genes (Hodges et al., 2011; Ji et al.,
2010; Bock et al., 2012; Kaaij et al., 2013; Beerman et al., 2013;
Sun et al., 2014). That being said, these studies largely correlated
gene expression to methylation changes near transcription start
sites or within gene bodies. Thus, it remains possible that altered
methylation marks at more distal regulation regions such as en-
hancers would reveal a more direct regulatory role on gene tran-
scription (Cabezas-Wallscheid et al., 2014), though addressing
this possibility is challenging given that distal regulatory regions
remain poorly defined in most stem cell populations.
Another possibility unique to stem cells is that altered DNA
methylation marks established in the stem cell compartment
may not have a direct, autonomous effect on transcription ofCell Stem Cell 16, June 4, 2015 ª2015 Elsevier Inc. 615
Figure 3. Aberrant Age-Associated DNA Methylation in Stem Cells
Can Influence Gene Expression in Downstream Progeny
A mechanism in which DNA methylation changes in aged stem cells do not
directly affect the transcription of genes at the stem cell level but instead affect
the transcriptional profiles of downstream cells that inherit altered DNA
methylation marks acquired in the aged stem cell compartment.
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expression in downstream progeny because these heritable
marks are transmitted during the process of differentiation
(Figure 3). Consistent with this idea, one study showed that
many of the genes associated with altered DNA methylation
(both gains and losses) during HSC aging were not expressed
in the stem cell compartment, but instead were exclusively tran-
scribed in downstream lineages (Beerman et al., 2013). These
data suggest that these heritable epigenetic marks acquired
in the stem cell compartment during aging might alter stem cell
differentiation potential by either restricting or allowing access
to key lineage-specific genes, and the effects of these altered
marks may only be manifest in the transcriptional programs of
differentiated progeny (Beerman and Rossi, 2014).
Regulation of Stem Cell Function by Histone
Modifications
An additional layer of epigenetic regulation that does not directly
alter the nucleotide chemistry of DNA is mediated by histone
modifications. While DNA methylation can be thought of as a bi-
nary switch with two options, methylated or unmethylated, his-
tone modifications are substantially more complex. Four core
histone proteins, H2A, H2B, H3, and H4, form an octamer that
DNA is wound around, thereby compacting the genome. The un-
structured N-terminal tails of histones are accessible for post-
translational modifications, including acetylation, methylation,
phosphorylation, sumoylation, ubquitination, and others, that
change chromatin structure and accessibility. These modifica-
tions can act in concert either cooperatively or antagonistically
to regulate transcriptional activity. This Review will focus mainly
on histone acetylation and methylation, as these are two of the
most well-studied modifications in stem cells.
Histone Acetylation in Stem Cells and during Aging
Acetylation of histone tails alters the charge of the histone, loos-
ening compacted chromatin and allowing a more open and
permissive transcriptional state. Histone acetylation is catalyzed
by enzymes that either transfer an acetyl group onto a lysine—
histone acetyltransferases (HATs)—or remove the mark—his-
tone deacetylases (HDACs). The activity of HDACs and HATs616 Cell Stem Cell 16, June 4, 2015 ª2015 Elsevier Inc.is dynamic and tightly regulated, facilitating the ability of these
transient marks to precisely regulate cell-specific expression.
The critical role of HAT activity in stem cell function has been
revealed by numerous genetic studies. In the hematopoietic
system, the striking phenotypes associated with hemizygosity
of the CREB binding protein (CBP), including splenomegaly,
decreased bone marrow cellularity, and diminished B cell pro-
duction, suggest an important role for this HAT in HSC function
(Kung et al., 2000). Indeed, conditional ablation of Cbp led to
overall loss of HSCs, increased differentiation, and higher levels
of apoptosis (Rebel et al., 2002; Chan et al., 2011). Similarly, con-
ditional knockout of the HAT cofactor Trrap also led to loss of the
primitive compartment and rapid death due to severe anemia
and pancytopenia (Loizou et al., 2009). Mice in which the mono-
cytic leukemia zinc-finger protein MOZ, a HAT translocated in
human acute myeloid leukemia, has been genetically ablated
die during embryonic development with severe loss of HSCs
and other lineage-restricted progenitors (Katsumoto et al.,
2008). Together these results strongly suggest that proper his-
tone acetylation is required for HSC self-renewal.
Histone acetyltransferase activity has also been shown to be
important for homeostatic maintenance and function of neural
stem and progenitor cell compartments. CBP is necessary for
differentiation of NPCs because it acetylates promoters of
neuronal, astrocytic, and oligodendroglial genes, and loss of
CBP ultimately leads to cognitive deficits (Wang et al., 2010).
Loss of Trrap in NPCs leads to premature differentiation (Tapias
et al., 2014), whereas other acetyltransferases such asMoz and
Moz-related factor (MORF) have also been implicated in main-
taining NSCs (Perez-Campo et al., 2014; Sheikh et al., 2012)
suggesting that HATs can regulate both differentiation and
self-renewal of NPCs.
Eighteen mammalian HDACs have been identified and are
categorized into four families. Class I HDACs play a role in differ-
entiation and appear to have a high level of functional redun-
dancy. In intestinal stem cells, simultaneous ablation of Hdac1
and Hdac2 leads to loss of differentiated cells, altered polariza-
tion, and increased cell death (Turgeon et al., 2013; Zimberlin
et al., 2015). Similar phenotypes occur in the hematopoietic sys-
tem where the loss of class I HDACs leads to decreased bone
marrow cellularity (Wilting et al., 2010) and in certain instances,
loss of stem and progenitor cells (Heideman et al., 2014). In
both the intestine and bone marrow, these phenotypes were
not attributed to loss of self-renewal potential of the stem cell
compartments, but rather to an increased level of apoptosis.
Drug-induced inhibition of HDACs in NPCs also leads to altered
differentiation associated with elevated apoptosis (Hsieh et al.,
2004), similar to the phenotypes seen in blood and intestinal
stem cells. Additionally in NSCs, simultaneous knockdown of
HDAC3, HDAC5, and HDAC7 (class I and II HDACs) leads to up-
regulation of the cell-cycle regulator Cdkn1a (p21) and inhibits
proliferation (Sun et al., 2007), similar to the p21 induction and
cell-cycle arrest in human mesenchymal stem cells after drug-
induced inhibition of HDAC activity (Lee et al., 2009).
Class III HDACs encompass the Sirtuin family, which are
uniquely NAD+ dependent, whereas the other HDAC families
require Zn2+ as a cofactor. In mesenchymal stem cells, SIRT1
is linked to differentiation toward bone and cartilage (Simic
et al., 2013). In adult NSCs, loss of SIRT1 leads to increased
Figure 4. Histone Modifications in an Adult Stem Cell Compartment
during Aging Cooperate to Influence Transcriptional Competence
A schematic of histone modification dynamics in stem cells as a consequence
of aging and their influence on gene expression. The complex histone code
presents many combinations to repress, activate, or prime expression of
transcripts.
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igodendrocytes (Rafalski et al., 2013), and similarly SIRT2 also
acts to impede differentiation toward oligodendroglia (Li et al.,
2007). Interestingly, though these two HDACs inhibit oligoden-
drocyte differentiation, glial cells have less global acetylation
compared to NPCs or neurons (Hsieh et al., 2004); thus, acetyla-
tion of specific SIRT targets must be important for astrocyte and
oligodendroctye differentiation. Similarly, SIRT1 also seems to
play a role in directing epidermal stem cell differentiation by pro-
moting keratinocyte production (Ming et al., 2014). In HSCs and
muscle satellite cells, loss of SIRT1 leads to premature differen-
tiation, thereby implicating SIRT1 as a regulator of self-renewal in
these cells (Ryall et al., 2015; Rimmele´ et al., 2014; Matsui et al.,
2012). Additionally, SIRT1 regulates quiescence of HSCs, with
loss of SIRT1 leading to certain phenotypes reminiscent of aging
(Rimmele´ et al., 2014; Singh et al., 2013). Robust SIRT1 activity is
also implicated in maintaining quiescence of muscle satellite
cells, and decreased activity of SIRT1—as measured by
increased H4K16ac—is associated with decreased NAD+ levels
in the activated muscle satellite cells (Ryall et al., 2015). The
elevated level of H4K16ac in these activated stem cells was
attributed to the metabolic shift away from fatty acid oxidation
to glycolysis during activation. Interestingly, though quiescent
HSCs utilize glycolysis rather than oxidative phosphorylation
and thus have low levels of available NAD+, SIRT1 activity still
appears to be required to regulate histone acetylation to main-
tain proper HSC function and possibly aging (Rimmele´ et al.,
2014).
Direct histone modification analysis in adult stem cell popula-
tions during aging is challenging, as conventional chromatin IP
technology requires a sizeable number of cells to analyze and
most adult stem cell populations are quite rare. To circumvent
this hurdle and globally examine acetylation at H4K16
(H4K16ac), immunostaining was used to assess levels of
H4K16ac in HSCs during aging (Florian et al., 2012) (Figure 4).
Interestingly, a sub-population of agedHSCs showed decreased
levels and markedly altered cellular distribution of H4K16ac, in
contrast to young HSCs with high levels of polarized H4K16ac
expression. The altered H4K16ac in these aged HSCs was
reversed by pharmacological inhibition of Cdc42 concomitantwith partial restoration of HSC function (Florian et al., 2012).
Although the precise role that altered H4K16ac plays in aged
HSCs is unknown, H4K16 hypo-acetylation has been shown to
impede DNA damage response and repair of double-strand
breaks (Sharma et al., 2010; Li et al., 2010), and thus H4K16
hypo-acetylation in aged HSCs could contribute to the accumu-
lation of DNA damage observed in the aged HSC compartment
(Rossi et al., 2007; Ru¨be et al., 2011; Yahata et al., 2011; Wang
et al., 2012; Beerman et al., 2014).
Histone Methylation in Stem Cells and during Aging
In contrast to histone acetylation, methylation can serve as a
context-dependent repressive or permissive mark, and it gener-
ally regulates gene expression indirectly by altering interactions
with other proteins. Although methylation occurs on both lysine
and arginine residues, most stem cell studies examine the
methylation at lysine residues, catalyzed by histonemethyltrans-
ferases (HMTs) containing a SET (Su(var)3-9, Enhancer of Zeste,
Trithorax) domain. We will focus on the role of the largely acti-
vating marks of methylation on H3K4, the repressive methylation
at H3K27, and bivalent domains in the regulation of tissue-spe-
cific stem cells and aging.
H3K4me Primes Gene Expression in Stem Cells
Proper regulation of H3K4me has been implicated in HSC self-
renewal (Stewart et al., 2015) and in regulating proper differenti-
ation (Kerenyi et al., 2013; Cellot et al., 2013). Interestingly,
mono- and di-methylation of H3K4 at putative enhancer regions
in HSCs do not directly regulate active transcription in the
stem cell compartment, but they instead have been implicated
in priming genes for expression in downstream progeny by es-
tablishing a permissive state that only becomes transcriptionally
active upon differentiation (Attema et al., 2007; Cui et al., 2009;
Orford et al., 2008). Similarly, loci marked with H3K4me1 in
NPCs denote genes poised for expression, while those con-
taining both H3K4me1 and K3H27ac are actively transcribed
(Creyghton et al., 2010; Rada-Iglesias et al., 2011). In NPCs,
specific H3K4me1 marks found in concert with H3K27ac were
predominantly present near actively expressed genes important
for NPC function, whereas marks of H3K4me1 alone were pre-
sent in enhancer regions of genes that only become expressed
in differentiated neural cells (Creyghton et al., 2010). Similar to
H3K4me1, H3K4me3 alone also does not always predict gene
expression, but it instead marks initiation of transcription
(Guenther et al., 2007). For example, quiescent muscle satellite
cells show marks of H3K4me3 at genes not expressed during
quiescence but which subsequently become actively tran-
scribed when the satellite cells are activated (Liu et al., 2013).
These studies indicate that stem cells use histone methylation
to establish a poised transcriptional state, priming genes for
expression upon activation or differentiation.
The importance of H3K4me gene expression priming in
adult stem cells suggests that altered methylation of H3K4
may be involved in stem cell aging. To explore this, H3K4me3
was recently examined in HSCs isolated from young and old
mice, revealing that this mark increases with age and covers
broader regions, as compared to those found in young HSCs
(Sun et al., 2014) (Table 1). Furthermore, these permissive
H3K4me3 marks were correlated, to a certain extent, with age-
associated gene expression changes in the HSC compartment
(Sun et al., 2014), though how these altered marks correlatedCell Stem Cell 16, June 4, 2015 ª2015 Elsevier Inc. 617
Table 1. Histone Modifications in Adult Stem Cell Compartments during Aging Cooperate to Influence Transcriptional Competence
Primary Mark Secondary Mark Stem Cell Population Transcriptional State Aging Reference
H3K4me1 NSC primed N.S Creyghton et al., 2010
H3K27ac NSC active N.S Creyghton et al., 2010
H3K27me3/H3K4me3 HSC primed N.S Cui et al., 2009
HSC active N.S Cui et al., 2009
H3K4me2 HSC primed N.S Attema et al., 2007:
Orford et al., 2008
H3K4me3 satellite SC primed/active no sig. change Liu et al., 2013
H3K27me3 satellite SC primed increase of H3K27me3 Liu et al., 2013
HSC primed/active increase Sun et al., 2014
H3K27me3 HSC primed increase of H3K27me3 Sun et al., 2014
hair follicle SC primed/active N.S Lien et al., 2011
H3K27me3 hair follicle SC primed N.S Lien et al., 2011
mesenchymal SC primed/active N.S Noer et al., 2009
H3K27me3 mesenchymal SC primed N.S Noer et al., 2009
H3K27me1 HSC active N.S Cui et al., 2009
H3K27me3 HSC repressive no sig. change Sun et al., 2014
satellite repressive increase Liu et al., 2013
H4K16ac HSC active decrease Florian et al., 2012
Histone modifications in stem cells, their effect, alterations associated with aging, and references. N.S, not studied.
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In contrast to what is observed in HSCs, examination of
H3K4me3 in muscle satellite cells showed few differences be-
tween cells isolated from young and aged animals (Liu et al.,
2013) (Table 1). However, unlike HSCs, which give rise to a
very large repertoire of effector cell types, satellite cells only
give rise to one effector cell type, and thus the importance of
H3K4 priming and how this is altered during aging may reflect
this difference.
H3K27 Methylation Controls Stem Cell Function during
Homeostasis and Aging
Another extensively studied histone mark is methylation of lysine
27 on histone 3 (H3K27). The mono-methylated form of H3K27 is
the least well characterized, but it has recently been demon-
strated to be associated with permissive gene expression, while
the other two forms of H3K27me (H3K27me2/me3) are most
often negatively correlated with gene expression.
H3K27 methylation marks are added by the polycomb repres-
sive complex 2 (PRC2), a complex that includes EED, SUZ12,
and the catalytically active subunit EZH2. Numerous studies
have shown that PRC2 is required for the proper function of mul-
tiple stem cell compartments. In HSCs, overexpression of Ezh2
preserves stem cell potential during serial transplantation (Kam-
minga et al., 2006) and loss of Eed leads to HSC exhaustion (Xie
et al., 2014a). Similarly, EZH2 is required for muscle satellite cell
self-renewal (Woodhouse et al., 2013; Juan et al., 2011) and con-
ditional knockout of Ezh2 leads to loss of muscle regenerative
potential and an ineffective return to quiescence after stimulation
(Woodhouse et al., 2013). Ezh2 is only expressed in active NPCs,
not in quiescent NSCs, and loss of Ezh2 drives overall decrease
of neurogenesis (Zhang et al., 2014), suggesting that H3K27
methylation is important for proper differentiation in adult neural
progenitors but may not be required for self-renewal.618 Cell Stem Cell 16, June 4, 2015 ª2015 Elsevier Inc.Ezh1 can also provide enzymatic activity for the PRC2 com-
plex through binding of EED and SUZ12, and in some instances
it can compensate for loss of Ezh2 (Shen et al., 2008); however,
EZH1 and EZH2 appear to have distinct chromatin binding prop-
erties (Margueron et al., 2008). EZH1 regulation of mono- and
di-methylation at H3K27 in adult HSCs is necessary for both dif-
ferentiation and self-renewal (Hidalgo et al., 2012), and EZH1 has
the capacity to maintain H3K27me1 in an EED-dependent
manner (Shen et al., 2008). In the absence of EZH2, EZH1-medi-
ated H3K27me3 is sufficient for normal adult HSC potential (Xie
et al., 2014a). Combined loss of both Ezh1 and Ezh2 has func-
tional consequences in skin stem cells as well, and it is associ-
ated with global loss of H3K27me3 (Ezhkova et al., 2011).
Suz12 knockdown also leads to loss of HSC maintenance and
enhanced differentiation toward both lymphoid and myeloid lin-
eages upon transplantation (Kinkel et al., 2015). These results
are phenocopied after knockdown of JARID2, a protein associ-
ated with the core PRC2 complex. Interestingly, the number of
H3K27me3marks is mostly unchanged in aged HSCs compared
to young, but there is a broadening of the coverage and intensity
of the H3K27me3 signal in aged HSCs (Sun et al., 2014). Simi-
larly, aged quiescent satellite cells also display increased
coverage and intensity of H3K27me3 (Liu et al., 2013). How alter-
ation of H3K27me3 during aging impacts stem cell function in
muscle and blood is still unresolved, though it is possible that
this repressive mark restricts the regenerative potential of these
stem cells, which diminishes with age.
Resolution of Bivalent Domains in Adult Stem Cells
during Differentiation and with Aging
Loci marked by both the active H3K4me3 and repressive
H3K27me3 in ESCs are termed bivalent domains (Bernstein
et al., 2006). Many of these loci are critical for lineage commit-
ment, and bivalent status is thought to serve as a priming
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lineage genes upon differentiation (Bernstein et al., 2006;Mikkel-
sen et al., 2007). Many bivalent domains resolve to either
H3K4me3- or H3K27me3-only states in NPCs derived from
ESCs, yet interestingly a substantial fraction of bivalent domains
persist in NPCs (Mikkelsen et al., 2007). Similarly, unique bivalent
domains are found in both hair follicle stem cells andmuscle sat-
ellite cells (Liu et al., 2013; Lien et al., 2011), suggesting a poten-
tial role for these domains in tissue-specific stem cells. Given
that tissue-specific stem cells have the potential to differentiate
into all effector cells of their respective tissues, it has been
proposed that bivalent domains can facilitate the activation of
cell-specific programs and repression of lineage-inappropriate
programs during differentiation. Indeed, bivalent domains are
present at lineage-specific genes in satellite cells, HSCs, and
mesenchymal stem cells (Liu et al., 2013; Sun et al., 2014;
Noer et al., 2009), and it is possible that during differentiation,
bivalent domains present in the stem cell compartment are
resolved to H3K4me3- or H3K27me3-only states, thereby
restricting lineage commitment. Consistent with this, the fre-
quency of bivalent domains is highest in HSCs compared to
downstream multi-potent progenitors, lineage-restricted pro-
genitors, and terminally differentiated cells, with a progressive
diminution of bivalent domains during differentiation (Weishaupt
et al., 2010). These data suggest an important mechanistic
role for the resolution of bivalency in the orchestration of
hematopoietic lineage commitment. Whether such a mecha-
nism governs differentiation of other tissue-specific stem
cells that give rise to multiple effector cell types is currently
unknown.
Dysregulation of lineage potential is associated with aging of
most tissues, and thus examination of bivalent domains in
aged populations of stem cells could provide insight into loss
of lineage potential. Interestingly, in aged HSCs, there are both
gains and losses of bivalent domains compared to those found
in young HSCs (Sun et al., 2014) (Figure 4). The emergence of
novel bivalent domains in aged HSCs consisted mostly of gains
of repressive H3K27me3 marks on regions that only had
H3K4me3 activation marks in young HSCs. The age-associated
acquisition of new bivalent domains occurred at an 4-fold
higher rate compared to loss of these domains, which were
dominated by loss of H3K4me3 (Sun et al., 2014) (Figure 4). Simi-
larly, in muscle satellite cells, aging-associated gains of novel
bivalent domains were attributed to gains of H3K27me3 repres-
sive marks on loci marked only for activation in young satellite
cells (Liu et al., 2013) (Table 1, Figure 4). Though not fully
explored in these studies, the potential restriction of genes that
were in a permissive state in young stem cells, together with
loss of the permissive H3K4me3 mark on bivalent domains
present in young stem cells, may serve to functionally restrict
the potential of the aged stem cells. Further examination of
how these novel age-associated bivalent domains resolve or
are maintained in differentiated progeny upon vertical transmis-
sion from the stem cell compartment will provide insights
into how aging-associated alterations of these marks are fully
manifest.
Furthermore, the complex nature of the histone code suggests
that H3K4me3 and H3K27me3 bivalent domains are not the only
histone marks used to prime loci for expression or repressionduring aging. As technology improves to allow more robust,
high quality histone analysis on small cell numbers, it will be
interesting to address how these other heritable histone modifi-
cations affect the functional potential of stem cells and their
progeny during aging.
Epigenetic Crosstalk between DNA Methylation and
Histone Modifications in Aged Stem Cells
Emerging evidence suggests the existence of significant cross-
talk among multiple types of epigenetic modifications. As one
example, DNA methylation can be restricted by the histone
modification H3K4me, which has been demonstrated to inhibit
recruitment of DNMT3A and DNMT3B to active promoter re-
gions (Rose and Klose, 2014). This interaction between histone
and DNA methylation is further highlighted with the loss of
Kdm1b and Kdm1a, demethylases of mono- and di- methyl-
ated H3K4, which leads to disruption of DNA methylation, sug-
gesting that removal of histone methylation is necessary for
DNA methylation to occur at certain loci. In HSCs, the inability
to remove the H3K4me1/2 methylation due to loss of KDM1A/
LSD1 may prevent DNA methylation from repressing the HSC
self-renewal program, thus contributing to the loss of differen-
tiation potential observed in LSD1-deficient animals (Kerenyi
et al., 2013).
Similar to the antagonistic relationship of DNA methylation
with H3K4me, DNA methylation also appears to be mutually
exclusive with repressive H3K27memarks. H3K27me3 is readily
found at CpG island promoters that are hypo-methylated in
ESCs (Brinkman et al., 2012; Bartke et al., 2010). However, dur-
ing differentiation many of these regions acquire DNA methyl-
ation that replaces H3K27me3, perhaps as a more permanent
mark of lineage repression. Interestingly, this mechanism may
also be involved in restricting the potential of old stem cells
because regions marked by H3K27me in ESCs preferentially
become hyper-methylated in aged HSCs (Beerman et al.,
2013; Sun et al., 2014) and in agedmesenchymal stem cells (Fer-
na´ndez et al., 2015). It has recently been suggested that the
PRC2 complex directly interacts with DNMT3L (Neri et al.,
2013b) and TET1 (Neri et al., 2013a) to inhibit DNA methylation,
and because PRC2 core factors are significantly downregulated
in aged HSCs (Beerman et al., 2013; Sun et al., 2014), loss of this
direct PRC2mediation of repression may allow DNAmethylation
to accumulate.
In contrast to the largely antagonistic relationship of H3K27
and H3K4 methylation with DNAmethylation, H3K36me3, a hall-
mark of transcriptional elongation, appears to directly recruit and
interact with de novo DNA methyltransferases (Dhayalan et al.,
2010; Morselli et al., 2015). Consistent with this hypothesis, re-
gions in which H3K36me3 decreased in aged HSCs also dis-
played DNA hypo-methylation (Sun et al., 2014). Low levels of
H3K36me3 inversely correspond to expression variation associ-
ated with aging in both worms and flies (Pu et al., 2015), which
might suggest that H3K36me3 recruits DNA methylation to sta-
bilize gene expression patterns and that dysregulation or loss
of H3K36me could destabilize the aged transcription networks
through loss of DNA methylation. Together, these data suggest
that DNA methylation and histone modifications play a complex,
interactive role in maintaining and safeguarding stem cell poten-
tial during aging.Cell Stem Cell 16, June 4, 2015 ª2015 Elsevier Inc. 619
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Disease
Aging is invariably associated with increased disease prevalence
in all tissues; however, epigenetic contributions to disease
are most well characterized in blood. Hematopoietic aging is
associated with onset of many different malignancies including
myelodysplastic syndromes (MDS), leukemias (acute myeloid
leukemia [AML], CML, CLL, and CMML), myeloproliferative dis-
orders (CMD), myeloma, and lymphomas (Hodgkins and Non-
Hodgkin) (http://seer.cancer.gov). MDS encompasses a diverse
group of aging-associated disorders in which aberrant DNA
methylation patterns are associated with clonal expansion of
HSCs with abnormal differentiation potential (Will et al., 2012).
The stem cells that clonally expand in MDS patients often have
mutations in key epigenetic regulators and inappropriate DNA
methyl-silencing appears to be a functional driver of MDS
(Issa, 2013; Itzykson and Fenaux, 2014). The importance of dys-
regulated DNA methylation in the pathophysiology of MDS has
been clinically validated by treatment with potent inhibitors of
cytosine methylation, 5-Azacytidine and 5-Aza-20-deoxycytidine
(decitabine), that act by incorporating into DNA and inhibiting
DNA methyltransferases (Wijermans et al., 2000; Kantarjian
et al., 2006, 2007; Fukumoto and Greenberg, 2005). Though
the exact mechanism through which these agents act is un-
known, global demethylation appears to de-repress inappropri-
ately silenced genes, allowing for re-establishment of normal
stem cell function (Daskalakis et al., 2002). Clonally expanded
MDS HSCs are believed to serve as the reservoir through which
additional mutations promote progression to AML.
More generally, clonal expansion of epigenetically dysregu-
lated stem cells is emerging as a common mechanism underly-
ing pre-disease states (Figure 1). Consistent with this, loss of
Dnmt3a confers a competitive self-renewal advantage in HSCs
(Challen et al., 2012, 2014), and DNMT3A is frequently mutated
inmyeloid malignancies including AML,MDS, andmyeloprolifer-
ative neoplasms (MPNs) (Yang et al., 2015). Similarly, Tet2muta-
tions provide a selective advantage to HSCs leading to clonal
expansion (Ko et al., 2011; Moran-Crusio et al., 2011; Shide
et al., 2012), and TET2 mutations are common to MPNs, AML,
MDS, and B and T cell lymphomas (Ko et al., 2015; Xie et al.,
2014b). Furthermore, recent studies have begun to shed light
on the clonal evolution of AML, as pre-leukemic clones have
been found to almost invariably harbor mutations in critical
epigenetic regulators including DNMT3A, TET2, ASXL1, and
IDH1/2 (Corces-Zimmerman et al., 2014; Shlush et al., 2014;
Jan and Majeti, 2013). Interestingly, clonal hematopoiesis indic-
ative of clonally expanded stem cells is strikingly increased in the
peripheral blood of aged, non-diseased individuals, with over-
representation of mutations in the same cadre of epigenetic reg-
ulators (Busque et al., 2012; Jaiswal et al., 2014; Xie et al.,
2014b). Thus, though mutations in these genes are often associ-
ated with frank disease, it is also clear that epigenetic dysregu-
lation plays a significant role in establishing the pre-disease
state.
In addition to mutation of epigenetic regulators, there is also
evidence that direct alteration of epigenetic marks may also un-
derlie disease emergence. During aging, the most frequently
identified mutation in human stem and progenitors are cytosine
to thymine (C-T) transitions (Welch et al., 2012), which occur620 Cell Stem Cell 16, June 4, 2015 ª2015 Elsevier Inc.when an mC is deaminated. In many cancers, C-T transitions
are the most common mutation, but this transition is also highly
prevalent in aged, non-diseased blood (Kandoth et al., 2013;
Jaiswal et al., 2014; Xie et al., 2014b). Moreover, the direct con-
version of mC to thymine permanently alters potential DNA
methylation at that site. The age-associated loss of mC through
deamination together with mutations in epigenetic regulators
likely collaborate to underwrite the global DNA hypo-methylation
associated with cancer (Watanabe and Maekawa, 2010).
DNA hypo-methylation is not the only aberrant methylation
profile associated with cancer, as various cancers exhibit
DNA hyper-methylation at specific promoter-associated regions
(Esteller, 2003) that are over-representated as targets of PcG
proteins (Widschwendter et al., 2007). Again, hyper-methylation
at PcG targets is similar to phenotypes seen in aged stem cells,
where atypical DNA methylation occurs on regions that are typi-
cally regulated by H3K27me3 (Maegawa et al., 2010; Beerman
et al., 2013; Sun et al., 2014). Interestingly, ASXL1, which is
frequently mutated in pre-leukemic clones, is a member of the
PcG family, andmutations ofASXL1 result in loss of PRC2-medi-
ated tri-methylation of H3K27 (Abdel-Wahab et al., 2012).
Further, complete loss of ASXL1 in mice leads to onset of MDS
that is associated with global loss of H3K27me3 and H3K4me3
(Wang et al., 2014). This loss of antagonistic histone methylation
could allow for accumulation of DNA methylation at these loci
typically associated with histone modifications (as discussed
above), and aberrant DNA methylation could contribute to the
MDS phenotypes. Similarly, EZH2 is also frequently mutated in
cancers and MDS, further implicating a mechanism by which
diminished PRC2 regulation could lead to aberrant DNA methyl-
ation at histone-regulated regions.
Cumulatively these studies demonstrate that epigenetic dys-
regulation plays a central role in cancer development in blood
from a pre-disease state through to the emergence of frank dis-
ease. They also raise the possibility that targeted epigenetic
therapies may be effective in treating such diseases (Neff and
Armstrong, 2013).
Coda
Unlike genomic lesions that arise during aging, age-associated
epigenetic alterations are not permanent. This raises the possi-
bility that resetting the epigenetic landscape of aged stem cells,
either globally or in a targeted fashion, may be sufficient to
restore function to a youthful level. Indeed, this concept was
recently tested in a study demonstrating that aged hematopoiet-
ic progenitors which were reprogrammed to pluripotency and
then re-differentiated to blood cells no longer exhibited the char-
acteristic functional decline of aged HSCs (Wahlestedt et al.,
2013). This study provides proof of principle that resetting epige-
netic landscapes via reprogramming to a pluripotent state is suf-
ficient to rejuvenate the functional potential of aged stem cells.
Stem cell rejuvenation has also been achieved in muscle sat-
ellite cells and NSCs using the experimental paradigm of heter-
ochronic parabiosis, in which the circulatory systems of young
and old mice are surgically conjoined (Conboy et al., 2005; Sinha
et al., 2014; Katsimpardi et al., 2014). The exposure to a youthful
systemic environment was able to restore functional potential to
the stem cell compartments of the old parabiont, and though the
epigenome was not examined in these studies, it will be very
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cell function mediated by heterochronic parabiosis is dependent
upon re-establishment of a youthful epigenetic profile.
Though few in numbers, the studies that have examined ag-
ing-associated epigenetic alterations in stem cell compartments
have demonstrated that by and large the stem cell epigenome is
relatively stable during aging, with only a small number of loci
consistently altered (Beerman et al., 2013; Ferna´ndez et al.,
2015; Liu et al., 2013; Sun et al., 2014). This raises the possibility
that targeted restoration of relatively few aberrant epigenetic
marks may be sufficient to rejuvenate the functional potential
of aged stem cells. Until recently, however, this type of directed
epigenetic manipulation was not possible, and the only available
tools for modulating epigenomic states did so on a global scale.
The advent of targeted genome editing tools such as Cas9/
CRISPR (Jinek et al., 2012) or TALENs (Bedell et al., 2012), and
the repurposing of these tools to interrogate locus-specific
epigenetic marks, promises to reshape how epigenetic marks
are manipulated and studied. Indeed, nuclease-deficient Cas9
or TALEs can be fused to the catalytic domains of different
epigenetic regulators, offering the potential to direct locus-
specific alteration of epigenetic marks (Kearns et al., 2015; Hilton
et al., 2015; Mendenhall et al., 2013; Konermann et al., 2013).
Such technologies, together with the growing number of studies
establishing both the location and specific epigenetic marks
altered during stem cell aging, provide a powerful means through
which aging-associated epigenetic dysregulation can be studied
and perhaps eventually mitigated.
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